Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics for COVID-19. Here, we e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:bioRxiv
Päätekijät: Bates, Timothy A., Weinstein, Jules B., Farley, Scotland E., Leier, Hans C., Messer, William B., Tafesse, Fikadu G.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Cold Spring Harbor Laboratory 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402058/
https://ncbi.nlm.nih.gov/pubmed/32766589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.30.229377
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia